Accretion Nutraveda IPO Subscription Status
Accretion Nutraveda IPO was subscribed 1.77 times when bidding closed on 30 Jan 2026: QIB 1.01x, NII 1.8x, Retail 2.19x.
The Accretion Nutraveda IPO has been subscribed 1.77x times overall. Retail investors have shown interest with bids for 2.19x the shares available. The Non-Institutional Investor (NII) category has been subscribed 1.8x. Qualified Institutional Buyers (QIBs) have subscribed 1.01x. Data last updated on 03 Sep, 02:37 PM.
The IPO subscription period has ended. The issue opened on 28 Jan, 2026 and closes on 30 Jan, 2026. The shares are expected to list on stock exchanges on 04 Feb, 2026.
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | 3,67,000 of 3,64,000 | 1.01x |
| NII | 6,69,000 of 3,72,000 | 1.8x |
| Retail | 14,04,000 of 6,40,000 | 2.19x |
| TOTAL | 24,40,000 | 1.77x |
Application-wise breakup (estimated)
Approximate application counts — the exchanges don't publish these during bidding. Estimated from shares bid using the typical application size seen in recent IPOs' Basis of Allotment data. Final counts appear here once the Basis of Allotment is out.
| Category | Est. Applied | Times | |
|---|---|---|---|
| Retail max 605 | 695 | 1.15x | |
| TOTAL (EST.) | 695 |
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 45.7% for a single lot.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
30 Jan 2026
Day 3 |
1.61x | ▼ | |
|
QIB1.01x
NII1.77x
Retail1.86x
|
|||
|
29 Jan 2026
Day 2 |
0.30x | ▼ | |
|
QIB0.00x
NII0.52x
Retail0.33x
|
|||
|
28 Jan 2026
Day 1 |
0.19x | ▼ | |
|
QIB0.00x
NII0.34x
Retail0.21x
|
|||
Accretion Nutraveda SME IPO dates
From the bidding window to listing. Today is 13 October.
- Open 28 Jan 2026
- Close 30 Jan 2026
- Allotment 02 Feb 2026
- Refund/credit 03 Feb 2026
- Listing 04 Feb 2026
Accretion Nutraveda IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Accretion Nutraveda IPO?
As of IPO close date (30 Jan, 2026), the Accretion Nutraveda IPO is subscribed 1.77x times. Retail category is 2.19x, and NII is 1.8x subscribed.
When is the allotment date for Accretion Nutraveda IPO?
The allotment for Accretion Nutraveda IPO is expected to be finalized on 02 February, 2026.
What is the GMP of Accretion Nutraveda?
The Grey Market Premium (GMP) for Accretion Nutraveda is currently ₹65, indicating a potential listing gain of 50%.
When will Accretion Nutraveda IPO list on the stock market?
Accretion Nutraveda is scheduled to list on BSE and NSE on 04 February, 2026.
What are the chances of getting allotment in Accretion Nutraveda IPO?
The retail category is oversubscribed at 2.19x, meaning allotment is by lottery. Statistically, approximately 1 in 3 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 1.01x mean for Accretion Nutraveda IPO?
Moderate — QIBs have subscribed 1.01x. Institutional demand is present but not overwhelming. Watch for any last-minute QIB surge on the final day.
How to check Accretion Nutraveda IPO allotment status?
After the allotment date (02 Feb, 2026), you can check your Accretion Nutraveda IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Accretion Nutraveda SME IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.